WHO further delays emergency use authorisation for Covaxin over technical issues: Report

NEW DELHI: In a significant setback to main Indian vaccine producer Bharat Biotech, the World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for its COVID-19 vaccine Covaxin. Media experiences mentioned quoting sources that the worldwide well being watchdog has despatched extra technical queries to its producer Bharat Biotech.

All this comes days after Bharat Biotech claimed that it has submitted all information required for clearance of Covaxin

Though there is no such thing as a official affirmation round it as but, the delay is prone to adversely have an effect on Indians’, particularly college students’, planning to journey overseas.

Without EUA, Bharat Biotech-manufactured Covaxin won’t be thought of an accepted vaccine by most nations world wide. 

Interestingly, Union Health Ministry had lately given indications that the worldwide physique was probably to provide its nod to Covaxin anytime quickly.

“There is a procedure of submitting the documents for approval. WHO’s emergency use authorisation to Covaxin is expected soon,” Dr Bharati Pravin Pawar, Union Minister of State within the Health Ministry, had mentioned final Friday, based on information company ANI.

Earlier, Dr VK Paul, Chairperson of the National Expert Group on Vaccine Administration, had additionally mentioned that WHO’s approval for Covaxin was prone to come earlier than the top of this month.

According to Bharat Biotech, Phase III medical trials of Covaxin had demonstrated an efficacy price of 77.8 per cent.

Covaxin, together with Covishield, was the vaccine first authorised by India in its huge nationwide inoculation drive in opposition to COVID-19 launched in January this yr. Others just like the Russia-made Sputnik have been added to the nation’s armoury solely later.

Covishield is the one India-made vaccine on the WHO record now. It is manufactured by the Serum Institute of India in Pune and was developed by researchers at Oxford University and pharmaceutical agency AstraZeneca.

The WHO has, until now, additionally accepted vaccines manufactured by Pfizer-BioNTech, Johnson and Johnson, Moderna, and Sinopharm.

 Live TV